Back to Journals » Breast Cancer: Targets and Therapy » Volume 17
Breast Cancer: Targets and Therapy
- View all (710)
- Volume 18, 2026 (59)
- Volume 17, 2025 (104)
- Volume 16, 2024 (76)
- Volume 15, 2023 (79)
- Volume 14, 2022 (41)
- Volume 13, 2021 (58)
- Volume 12, 2020 (27)
- Volume 11, 2019 (32)
- Volume 10, 2018 (24)
- Volume 9, 2017 (64)
- Volume 8, 2016 (26)
- Volume 7, 2015 (36)
- Volume 6, 2014 (20)
- Volume 5, 2013 (13)
- Volume 4, 2012 (22)
- Volume 3, 2011 (16)
- Volume 2, 2010 (9)
- Volume 1, 2009 (4)
Archive: Volume 17, 2025
- default (104)
- Nanoparticles for Breast Cancer Treatment (1)
- Antibody-Drug Conjugates for Breast Cancer Treatment (1)
Introducing a New Hypothesis in the Genesis of Breast Cancer: An Integrative Review
Andrade Pachnicki JP, Cayet CM, dos Santos DAH, Junkes GB, Petry J, Hibarino MEM, Lodi Carvalho VL
Breast Cancer: Targets and Therapy 2025, 17:1493-1504
Published Date: 31 December 2025
Noncoding RNAs, Vital Players in Breast Cancer Metastasis
Kang Y, Wang X, Liu Y, Cao J, Lin J, Qiao G
Breast Cancer: Targets and Therapy 2025, 17:1463-1492
Published Date: 30 December 2025
Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker
Gou Y, Li Y, Wang Y, Ma H, Li H, Geni R, Ismtula D, Guo C
Breast Cancer: Targets and Therapy 2025, 17:1439-1461
Published Date: 30 December 2025
Inetetamab-Based Regimens for Patients with HER2-Positive Metastatic Breast Cancer: A Real-World Retrospective Study
Chen L, Huang J, Chen X, Lan X, Song L, Xie X, Bai X, Du C
Breast Cancer: Targets and Therapy 2025, 17:1427-1437
Published Date: 30 December 2025
Neuregulin-1 Secreted by Cancer-Associated Fibroblasts Promotes Growth of Triple-Negative Breast Cancer
Xu L, Xu H, Jiang D, Song S, Wang G, Zhang X, Zhang Y, Qian J, Kang J, Cai F
Breast Cancer: Targets and Therapy 2025, 17:1413-1425
Published Date: 26 December 2025
Down-Regulation of lncRNA CKMT2-AS1 Predicts Poor Prognosis and Promotes Breast Cancer Progression
Xue D, Hou R, Xu H, Li X
Breast Cancer: Targets and Therapy 2025, 17:1397-1411
Published Date: 26 December 2025
Inavolisib-Based Therapy for PIK3CA-Mutated Advanced Male Breast Cancer: A Cost-Effectiveness Analysis
Huang X, Lin S, Lin R, Luo S, Huang P, Zeng D
Breast Cancer: Targets and Therapy 2025, 17:1385-1396
Published Date: 26 December 2025
Differential TGF-β1/SMAD4 Signaling Regulates PMN-MDSC Differentiation and Reshapes the Immune Microenvironment in Breast Cancer
Cao J, Qiao E, Shao H, Wang C, Xia M, Qin B
Breast Cancer: Targets and Therapy 2025, 17:1369-1383
Published Date: 26 December 2025
The Landscape of Potential Targeted Treatments and Chemotherapy Efficacy Biomarkers for TNBC
Kang Y, Liu Y, Liang Z, Zhang S, Qiao G
Breast Cancer: Targets and Therapy 2025, 17:1341-1367
Published Date: 26 December 2025
Exploratory Research of Intraductal Chemotherapy to Control the Focal Breast Lesion of Breast Cancer
Lin X, Li X, Wei Q, Yuan H, Zhong M, Qiao J, Gong J, Li Y
Breast Cancer: Targets and Therapy 2025, 17:1321-1339
Published Date: 25 December 2025
Management Strategies and Outcomes in HR+/HER2− Metastatic Breast Cancer Receiving CDK4/6 Inhibitors and Subsequent Therapies
Pogoda K, Pawlik H, Balata A, Czopowicz M, Bak A, Twardowska I, Meluch M, Wojda M, Mlodzinska A, Szombara E, Sienkiewicz R, Konieczna A, Brewczynska E, Lemanska I, Majstrak-Hulewska A, Gorniak A, Niwinska A, Nowecki Z
Breast Cancer: Targets and Therapy 2025, 17:1307-1319
Published Date: 24 December 2025
Clinical Prognostic Value of C-Reactive Protein-Albumin-Lymphocyte Index (CALLY) in Patients with Stage III Breast Cancer
Zhu M, Cheng R, Zhang K, Yue C, Guan S, Chen L, Wang J, Wang Y, Zhang B
Breast Cancer: Targets and Therapy 2025, 17:1293-1305
Published Date: 22 December 2025
IDO1, IL4I1: Novel Immune Checkpoints in Breast Cancer Tumor-Associated Macrophages
Shi A, An Y, Yun F, Liu X, Jia Y
Breast Cancer: Targets and Therapy 2025, 17:1279-1292
Published Date: 21 December 2025
Dexmedetomidine Suppresses Mitochondrial Autophagy and Apoptosis While Promoting Proliferation in Breast Cancer Cells in vitro via PI3K/AKT Signaling
Gu M, Xia Y, Qian J, Shao C, Li Y, Lu X, Qin X
Breast Cancer: Targets and Therapy 2025, 17:1265-1278
Published Date: 20 December 2025
Mendelian Randomization Integrating GWAS and eQTL Data Reveals DAAM1, a Potential Immune-Related Biomarker for Breast Cancer Prognosis
Chen G, Zhang K, Wang Y, Zhang Z, Cao J, Gao G, Yu C, Dai Y, Qiao G, Cong Y
Breast Cancer: Targets and Therapy 2025, 17:1247-1263
Published Date: 17 December 2025
Beyond The Age Limit: A Comparative Study (<70 Vs ≥70 Years) in Breast Cancer Characteristics and Surgical Management in Women
Buyukasik S, Kankaya B, Altundal YE, Ozgul M, Kapan S
Breast Cancer: Targets and Therapy 2025, 17:1231-1246
Published Date: 12 December 2025
The Modified Shuyu Pill Inhibits the Formation of Pre-Metastatic Niches in Triple-Negative Breast Cancer by Reducing the Number of Myeloid-Derived Suppressor Cells (MDSCs) via the JAK2/STAT3 Pathway
Huang Y, Meng Y, Lou X, Feng D, Ling X, Jin Y, Lin X, Xie S
Breast Cancer: Targets and Therapy 2025, 17:1213-1229
Published Date: 11 December 2025
ST6GAL1 Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer via the HIF-HK2 Signaling Pathway
Ren D, Xue D, Hou Z, Xu H, Li X
Breast Cancer: Targets and Therapy 2025, 17:1199-1211
Published Date: 9 December 2025
Common Biomarkers and Pathogenesis of Inflammatory Bowel Disease and Breast Cancer: Mendelian Randomization and Multi-Omics Studies
Zhang D, Guan Y, Tang H, Xue Q, Li X, Bin X, You F
Breast Cancer: Targets and Therapy 2025, 17:1183-1197
Published Date: 8 December 2025
Dual Receptor Targeting Ensures Uptake and Anticancer Efficacy of Low-Density Lipoprotein-Docosahexaenoic Acid Nanoparticles Across Breast Cancer Cell Subtypes
Bower J, Anwar A, Chaudhary J, Chen Z, Schumacher M, Debose-Boyd R, Corbin IR
Breast Cancer: Targets and Therapy 2025, 17:1159-1182
Published Date: 6 December 2025
Circular RNA DENND4C Regulates Cell Malignant Behaviors in Breast Cancer Through the miR-26a-5p/HSPA8 Axis
Guo M, Chang Y, Dai Y, Liu X, Shi S, Li J, Liu W, Han J
Breast Cancer: Targets and Therapy 2025, 17:1145-1157
Published Date: 2 December 2025
Tissue- and Cell-Type-Specific Genetic Regulation of CTBP1 in Breast Cancer: Integrative Analyses with Exploratory Single-Cell and Imaging Data
Hong M, Huang X, Xu Q, Ma Z, Ling K
Breast Cancer: Targets and Therapy 2025, 17:1133-1143
Published Date: 1 December 2025
Development and Validation of a Radiomics-Based Nomogram for Predicting HER-2 Status in Breast Cancer: A Retrospective Study with Small Validation Cohort
Qiu Q, Chen C, Chen J, Liao C, Tang L
Breast Cancer: Targets and Therapy 2025, 17:1119-1132
Published Date: 2 December 2025
Advances in DCE-MRI Radiomics for Non-Invasive Prediction of Breast Cancer Molecular Subtypes: Research Progress and Clinical Translation
Yu Z, Ma W, Zhang Y, Gao Y, Jie H, Jiang J, Huang C
Breast Cancer: Targets and Therapy 2025, 17:1111-1118
Published Date: 26 November 2025
Delayed Cardiac Dysfunction During Prolonged Use of Trastuzumab for the Treatment of HER2-Positive Metastatic Breast Cancer
Chen X, Lan X, Xiao L, Song L, Huang J, Xie X, Chen L, Bai X, Du C
Breast Cancer: Targets and Therapy 2025, 17:1101-1110
Published Date: 25 November 2025
Comprehensive Analysis and Experimental Validation of Single-Cell and Transcriptome Sequencing Reveal SGO2 as a Novel Biomarker for Breast Cancer
Li YF, Yuan Y, Chen C, Zhu ML, Xu SY, Wu SQ, Gao Y, Meng LW
Breast Cancer: Targets and Therapy 2025, 17:1083-1100
Published Date: 24 November 2025
Prognostic and Immunological Implications of Telomere Maintenance-Related Genes in Breast Cancer: A Mechanistic Exploration
Cao H, Gao F, Wang R, Xie Y, Li B
Breast Cancer: Targets and Therapy 2025, 17:1063-1082
Published Date: 12 November 2025
Preoperative Imaging Assessment of Lymphovascular Invasion in Breast Cancer: Current Evidence, Technical Advances, and Future Directions
Wang H, Huang C, Wang Y, Liu Y
Breast Cancer: Targets and Therapy 2025, 17:1051-1062
Published Date: 11 November 2025
The Learning Curve of Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy with Immediate Prepectoral Implant Reconstruction: CUSUM Analysis
Zhao R, He C, Jiang W, Lin S, Zhao Y
Breast Cancer: Targets and Therapy 2025, 17:1041-1050
Published Date: 8 November 2025
Circuit Weight Training Enhances Quality of Life and Functional Outcomes in Breast Cancer Survivors: A Randomized Controlled Trial
Helal ASF, Ali SM, Hassan MHI, Elrefaey BH, Zaki RM, Ibrahim ZM, Abdel Ghaffar HA
Breast Cancer: Targets and Therapy 2025, 17:1025-1039
Published Date: 8 November 2025
Demonstrating the Absence of Correlation Between Molecular Docking and in vitro Cytotoxicity in Anti-Breast Cancer Research: Root Causes and Practical Resolutions
Megantara S, Rusdin A, Budiman A, Puluhulawa LE, Ikram NKBK, Muchtaridi M
Breast Cancer: Targets and Therapy 2025, 17:1005-1023
Published Date: 5 November 2025
Stereotactic Accelerated Partial Breast Irradiation Using CyberKnife with Non-Invasive Skin Fiducial Marker Tracking in Early-Stage Breast Cancer: A Retrospective Study of Feasibility, Dosimetry, and Early Outcomes
Wei CW, Cheng MC, Yeh HL
Breast Cancer: Targets and Therapy 2025, 17:997-1004
Published Date: 29 October 2025
CLEC3A Promotes Immune Evasion and Tumor Progression by Enhancing PD-L1 Stability to Weaken T Cell Cytotoxicity in Luminal Breast Cancer
Chen C, Li H, Liu Y, Zhang X, Sun Y, Li X
Breast Cancer: Targets and Therapy 2025, 17:977-995
Published Date: 27 October 2025
Accuracy and Influencing Factors of Axillary Lymph Node Ultrasound Assessment After Neoadjuvant Chemotherapy in Breast Cancer
Peng LQ, Tang X, Yang GX, Zhu Y
Breast Cancer: Targets and Therapy 2025, 17:967-976
Published Date: 26 October 2025
Ambra1 Deficiency Inhibits the Proliferation of Breast Cancer Cells Through the Akt-FoxO1-p27 Pathway
Qin Y, Chen S, Tao D, Lin Q, Sun W
Breast Cancer: Targets and Therapy 2025, 17:949-965
Published Date: 21 October 2025
Exploring AI Approaches for Breast Cancer Detection and Diagnosis: A Review Article
Ali A, Alghamdi M, Marzuki SS, Tengku Din TADAA, Yamin MS, Alrashidi M, Alkhazi IS, Ahmed N
Breast Cancer: Targets and Therapy 2025, 17:927-947
Published Date: 21 October 2025
LINC00917 Promotes Bone Metastasis of Breast Cancer by Targeting the miR-491-5p/FOXP4 Axis
Qu X, Wang C, Xu Y, Yang X, Sun AB, Liu XY, Li JZ, Nie JY
Breast Cancer: Targets and Therapy 2025, 17:913-925
Published Date: 17 October 2025
Ki-67 Prediction in Breast Cancer: Integrating Radiomics From Automated Breast Volume Scanner and 2D Ultrasound Images via Machine Learning
Wei W, Xia F, Zhou W, Lu W, Zhang D, Ma Q, Xu X, Zhang C
Breast Cancer: Targets and Therapy 2025, 17:897-912
Published Date: 11 October 2025
Development and Validation of Machine Learning Models in Predicting Prognosis of Breast Cancer Patients with Lymph Nodes Metastasis Following Neoadjuvant Chemotherapy
Fan Y, Jin Y, Tian C, Zhang Y, Zhang C, Yu H, Liu S
Breast Cancer: Targets and Therapy 2025, 17:883-896
Published Date: 30 September 2025
Triple-Negative Breast Cancer on the Rise: Breakthroughs and Beyond [Response to Letter]
Agelidis A, Ter-Zakarian A, Jaloudi M
Breast Cancer: Targets and Therapy 2025, 17:877-881
Published Date: 29 September 2025
Triple-Negative Breast Cancer on the Rise or…? [Letter]
Lønning PE, Nikolaienko O, Knappskog S
Breast Cancer: Targets and Therapy 2025, 17:875-876
Published Date: 25 September 2025
Efficacy of Trastuzumab Deruxtecan in HER2-Positive and HER2-Low Metastatic Breast Cancer: A Real-World Retrospective Cohort Study in China
Yan Y, Jin Y, Lin M, Zeng C, Guo Q, Zhou T, Li DD, Zhang J
Breast Cancer: Targets and Therapy 2025, 17:863-873
Published Date: 25 September 2025
Clinical Management of Circulating Tumor DNA in Breast Cancer: Detection, Prediction, and Monitoring
Lu Y, Ren L, Yang M, Liu J
Breast Cancer: Targets and Therapy 2025, 17:851-861
Published Date: 25 September 2025
ANXA2 Regulates RANKL-Induced Osteoclast Differentiation Through STAT3 Signaling in Breast Cancer
Yuan J, Xin F, Wang R
Breast Cancer: Targets and Therapy 2025, 17:837-849
Published Date: 18 September 2025
Effects of Clinacanthus nutans Extracts on Cell Proliferation and Apoptosis in Triple-Negative Breast Cancer: Mechanistic Insights
Xu J, Long J, Li ZY, Wang C, Zhang Y, He H, Hu Q, Yin S, Li H, Wang N, Gao Q, Tang S, Zhu Y, Wang P, Feng R, Liu Y
Breast Cancer: Targets and Therapy 2025, 17:819-835
Published Date: 15 September 2025
Utility of Volatile Organic Compounds and Electronic Nose Technology for Breast Cancer Detection: A Systematic Review
Orduña-Medina FM, Díaz de León-Martinez L, Alarcón-Rivera GDD, Prieto-Gómez NA, Mizaikoff B, Alcántara-Quintana LE
Breast Cancer: Targets and Therapy 2025, 17:805-817
Published Date: 11 September 2025
The Role of The Xihuang Pill in Inhibiting Triple-Negative Breast Cancer Through Immunogenic Cell Death
Xu X, Li X
Breast Cancer: Targets and Therapy 2025, 17:793-803
Published Date: 5 September 2025
Investigation of Thrombocytopenia Associated with Trastuzumab Emtansine Treatment in Breast Cancer: A Retrospective Study in a Chinese Population
Zhang K, Wu S, Zhou Y, Chen H, Pan C
Breast Cancer: Targets and Therapy 2025, 17:781-791
Published Date: 5 September 2025
Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer
Aimaiti X, Wang Y, Ismtula D, Li Y, Ma H, Wang J, Elihamu D, Guo C
Breast Cancer: Targets and Therapy 2025, 17:755-779
Published Date: 29 August 2025
Age and Education Influencing Willingness in Men to Recommend Breast Cancer Screening: A Comparative Study of University Personnel and Clinical Attendees
Buyukasik S, Kankaya B, Altundal YE, Ozgul M, Atashbari F, Osman AAH, Alis H, Kapan S
Breast Cancer: Targets and Therapy 2025, 17:741-754
Published Date: 25 August 2025
Safety Profile and Predictors of Adverse Events of Incadronate Disodium in Treating Breast Cancer Patients with Bone Metastases: A Retrospective Study
Zhou S, Jiang M, Liu J, Zhang M, Li M, He M, Abudureheiyimu N, Wang W, Guan X, Ma F, Xu B, Li Q
Breast Cancer: Targets and Therapy 2025, 17:727-739
Published Date: 20 August 2025
Predicting Human Epidermal Growth Factor Receptor 2 Expression in Breast Cancer Based on Radiomics of MRI Habitat and US
Lin Z, Huang F, Wei L, Liao X, Gao Y
Breast Cancer: Targets and Therapy 2025, 17:711-725
Published Date: 15 August 2025
Mechanisms and Management of Albumin-Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer
Xu X, Han Q, Qiu S, Gao S, Ren C, Li X
Breast Cancer: Targets and Therapy 2025, 17:693-709
Published Date: 13 August 2025
Late Breast Cancer Recurrence Prediction: The Role of CTS5 and Progesterone Receptor Status
Carvalho GS, Gomes DM, Bretas GDO, Teixeira VBG, Bines J
Breast Cancer: Targets and Therapy 2025, 17:683-691
Published Date: 28 July 2025
Clinical Prognosis and Nomograms for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Patients Treated with Palbociclib and Endocrine Therapy
Song S, Sun L, Liu X, Zhang L, Li C, Liu Z, Liu F, Yu Z
Breast Cancer: Targets and Therapy 2025, 17:669-681
Published Date: 24 July 2025
Effectiveness of a Care Plan Based on the Multi-Theory Model in Reducing Fear of Disease Progression and Improving Quality of Life in Breast Cancer Patients: A Randomized Controlled Trial
Zhang J, Zhuang J, Chen X, Chu T, Zhang Q, Ma L, Zhou H, Wu Y, Chen L
Breast Cancer: Targets and Therapy 2025, 17:653-667
Published Date: 25 July 2025
N2 Neutrophils and Tumor Progression in Breast Cancer: Molecular Pathways and Implications
Obeagu EI
Breast Cancer: Targets and Therapy 2025, 17:639-651
Published Date: 23 July 2025
Peripheral TNF-α and CD8+/CD28+ T Lymphocytes as Alternatives for PD-L1 Prediction in Breast Cancer Tumor Microenvironment: Stratified by Neoadjuvant Therapy
Wu J, Ou X, Yuan K, Shi F, Zhou Q, Lyu S, Li Y, Zhao Y, Cao Y, Sun J, Song Q
Breast Cancer: Targets and Therapy 2025, 17:627-637
Published Date: 19 July 2025
A Machine-Learning Model for the Prediction of Triple-Negative Breast Cancer Based on Multiparameter MRI
Cai Y, Li Y, Wang W, Zhou Y, Wang J, Zhang L, Lu H
Breast Cancer: Targets and Therapy 2025, 17:611-625
Published Date: 15 July 2025
Simultaneous Implant and Dermal Flap Technique for Breast Reconstruction After Skin-Sparing Total Mastectomy for Breast Carcinoma
Agdoğan Ö, Gürdal özkan S
Breast Cancer: Targets and Therapy 2025, 17:599-610
Published Date: 14 July 2025
Exploring the Mechanism of Lianqiao Jinbei Decoction Inhibiting HER2-Positive Breast Cancer Based on Network Pharmacology and Experimental Verification
Li D, Liu X, Fan H, Dong J, Wei L, Guo N, Wang Z, Du Z, Liu J, Zhao X, Tian X, Han C, Yao X
Breast Cancer: Targets and Therapy 2025, 17:583-598
Published Date: 14 July 2025
Heterogeneity Assessment of Breast Cancer Tumor Microenvironment: Multiparametric Quantitative Analysis with DCE-MRI and Discovery of Radiomics Biomarkers
Ma W, Yang L, Zhang Y, Gao Y, Jie H, Huang C
Breast Cancer: Targets and Therapy 2025, 17:573-581
Published Date: 8 July 2025
Male Breast Cancer: Evaluating the Current Landscape of Diagnosis and Treatment
Ter-Zakarian A, Agelidis A, Jaloudi M
Breast Cancer: Targets and Therapy 2025, 17:567-572
Published Date: 5 July 2025
Advancements in Dalpiciclib for the Treatment of Breast Cancer Patients: A Review
Chen Z, Xie P, Chen Q, Ouyang J
Breast Cancer: Targets and Therapy 2025, 17:557-565
Published Date: 30 June 2025
Continuous Anlotinib Combined with Oral Vinorelbine has Shown Anti-Tumor Efficiency in Refractory HER2 Negative Advanced Breast Cancer
Huang JY, Zhang Y, Du CW
Breast Cancer: Targets and Therapy 2025, 17:545-555
Published Date: 28 June 2025
Current Strategies to Reducing Interval Breast Cancers: A Systematic Review
Goh RSJ, Chong B, Yeo S, Neo SY, Ng QX, Goh SSN
Breast Cancer: Targets and Therapy 2025, 17:531-544
Published Date: 27 June 2025
Triple-Negative Breast Cancer on the Rise: Breakthroughs and Beyond
Agelidis A, Ter-Zakarian A, Jaloudi M
Breast Cancer: Targets and Therapy 2025, 17:523-529
Published Date: 26 June 2025
Research Progress of PROTAC-Degraded CDKs in the Treatment of Breast Cancer
Zhao K, Zhang J, Yang Z, Wang R, Shi Y, Ji Y, Zhang S, Liu M
Breast Cancer: Targets and Therapy 2025, 17:511-521
Published Date: 13 June 2025
A Prognostic Nutritional Index-Based Nomogram to Predict Breast Cancer Metastasis: A Retrospective Cohort Validation
Chen Z, Gao H, Cheng M, Song C
Breast Cancer: Targets and Therapy 2025, 17:497-510
Published Date: 10 June 2025
Radiation-Based Multi-Modal Therapy Combining with Immunotherapy to Develop a Vaccine-Like Effective Treatment for Triple-Negative Breast Cancer
Dai M, Tian Z, Xu F, Yao B, Liang H, Li D, Wang J, Rong J, Liu T, Tang H, Lu H, Zhang W
Breast Cancer: Targets and Therapy 2025, 17:483-496
Published Date: 10 June 2025
ALKBH5 Promotes Breast Cancer Stemness Through Regulating Wnt/β-Catenin Signaling
Wang K, Wang K
Breast Cancer: Targets and Therapy 2025, 17:471-482
Published Date: 6 June 2025
CD151 Promotes Cancer Progression in Triple-Negative Breast Cancer by Inducing EMT through the MAPK Signaling Pathway
Lv H, Zhang B, Weng X, Li Y, Deng C, Wang R, Shi L, Yin Y
Breast Cancer: Targets and Therapy 2025, 17:455-470
Published Date: 28 May 2025
Promising Response to Neoadjuvant Chemotherapy Plus Immunotherapy in Metaplastic Breast Carcinoma
Tan Q, Li N, Wang Y, Du T, Liang G, Zhao Z, Tang J, Wu H
Breast Cancer: Targets and Therapy 2025, 17:447-454
Published Date: 23 May 2025
Barriers to Early Breast Cancer Diagnosis in Sudanese Women Before the War
Elamin HES, Elamin HES, Abd El-Raheem GOH, Noma M
Breast Cancer: Targets and Therapy 2025, 17:433-445
Published Date: 20 May 2025
Advances in Targeted Therapy for Brain Metastases in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer: A Focus on ADCs and TKIs
Rao B, Huo P, Lu J, Huang W
Breast Cancer: Targets and Therapy 2025, 17:423-432
Published Date: 19 May 2025
Naples Prognostic Score (NPS) as a Novel Prognostic Score for Stage III Breast Cancer Patients: A Real-World Retrospective Study
Miao Y, Yang R, Zhang B, Yang J, Yao L, Wang W, Liu X, Guo X, Jia H
Breast Cancer: Targets and Therapy 2025, 17:403-421
Published Date: 12 May 2025
Exploring the Potential of Chaihu-Danggui Tang in Breast Cancer Treatment Based on Network Pharmacology, Molecular Docking, and Experimental Validation
Liu Y, Zhang J, Lai Y, Wu C, Liu D, Liang R, Chen G, Jiang X
Breast Cancer: Targets and Therapy 2025, 17:385-401
Published Date: 10 May 2025
A Comparative Analysis of Mobile versus Stationary Mammography Units: Performance and Outcomes in a Breast Cancer Screening Program
Tari DU, De Lucia DR, Santonastaso R, Santarsiere M, Blasotti A
Breast Cancer: Targets and Therapy 2025, 17:373-383
Published Date: 7 May 2025
Immune and Metabolic Reprogramming Induced by Paclitaxel, Capecitabine and Eribulin in Breast Cancer: Insights into Therapeutic Targets
Hsiao HH, Patel R, Kalinski P, Takabe K, Ernstoff MS, Rosario SR, Gandhi S
Breast Cancer: Targets and Therapy 2025, 17:359-372
Published Date: 29 April 2025
Unveiling the Landscape of PD-L1 Expression and Tumor-Infiltrating Lymphocyte Subtypes in Advanced Triple-Negative Breast Cancer in Brazil
Dos Santos ALS, Da Silva JL, De Albuquerque LZ, Neto ALA, Da Silva CF, Cerva LAM, Small IA, Rodrigues FR, De Macedo FC, Marcelino CP, Batista PDM, Rego MADC, Borba MACSM, De Melo AC
Breast Cancer: Targets and Therapy 2025, 17:349-358
Published Date: 15 April 2025
Current Status of Breast Cancer Immunotherapy and Prognosis-Related Markers
Xu Y, Zhang B, Wu H, Wu Y
Breast Cancer: Targets and Therapy 2025, 17:339-348
Published Date: 15 April 2025
HGH1 Promotes Breast Cancer Progression Through the PI3K/AKT/NF-κB Signaling Pathway: Potential Role for Prognosis and Targeted Therapy
Hu W, Si D, Liu C, Tie D, Xu D, Li N
Breast Cancer: Targets and Therapy 2025, 17:325-337
Published Date: 14 April 2025
The Comprehensive Analysis of Weighted Gene Co-Expression Network Analysis and Machine Learning Revealed Diagnostic Biomarkers for Breast Implant Illness Complicated with Breast Cancer
Huang Z, Wang H, Pang H, Zeng M, Zhang G, Liu F
Breast Cancer: Targets and Therapy 2025, 17:305-324
Published Date: 10 April 2025
Exploration of Traditional Chinese Medicine Comprehensive Treatment of Triple Negative Breast Cancer Based on Molecular Pathological Mechanism
Zhu M, Liu Y, Wen Z, Tan H, Li S, Yu X, Luo H, Li D, Wang J, Qin F
Breast Cancer: Targets and Therapy 2025, 17:289-304
Published Date: 10 April 2025
Shear Wave Elastography: A Non-Invasive Approach for Assessing TGF-β1/MAPK Signaling Molecules and EMT in Breast Cancer
Huang S, Wang B, Jiang Y, Li S, Li J, Wang Z
Breast Cancer: Targets and Therapy 2025, 17:275-287
Published Date: 26 March 2025
Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review
Jie H, Ma W, Huang C
Breast Cancer: Targets and Therapy 2025, 17:265-274
Published Date: 17 March 2025
Genetic Alterations in HER2-Positive and Equivocal Breast Cancer by Immunohistochemistry
Tsai YF, Hsu CY, Chiu YN, Huang CC, Chou SH, Lin YS, Chao TC, Liu CY, Chiu JH, Tseng LM
Breast Cancer: Targets and Therapy 2025, 17:253-263
Published Date: 12 March 2025
Ultrasound-Guided Percutaneous Microwave Coagulation Studies on VX2 Rabbit Models for Breast Cancer Treatment and Ultrasound Imaging Assessment
Gao Q, Huang H, Shi JJ, Wang L, Li WM
Breast Cancer: Targets and Therapy 2025, 17:241-252
Published Date: 25 February 2025
Telomere Maintenance-Related Genes are Essential for Prognosis in Breast Cancer
Huang W, Wang W, Dong TZ
Breast Cancer: Targets and Therapy 2025, 17:225-239
Published Date: 24 February 2025
Tumor Microenvironment Modulation by Tumor-Associated Macrophages: Implications for Neoadjuvant Chemotherapy Response in Breast Cancer
Oner G, Praet MM, Stoop H, Devi GR, Canturk NZ, Altintas S, Van Berckelaer C, Berneman Z, Tjalma W, Koljenovic S, van Dam PA
Breast Cancer: Targets and Therapy 2025, 17:211-224
Published Date: 21 February 2025
Real-World Analysis of the Efficacy and Adverse Events of T-DM1 in Chinese Patients With HER2-Positive Breast Cancer
Gu H, Zhu T, Ding J, Yang Z, Qi S, Guo G
Breast Cancer: Targets and Therapy 2025, 17:201-210
Published Date: 21 February 2025
Radiomics Integration of Mammography and DCE-MRI for Predicting Molecular Subtypes in Breast Cancer Patients
Yang X, Li J, Sun H, Chen J, Xie J, Peng Y, Shang T, Pan T
Breast Cancer: Targets and Therapy 2025, 17:187-200
Published Date: 18 February 2025
Quality of Life in Breast Cancer Patients in Saudi Arabia: A Systematic Review
Aljadani FF, Nughays RO, Alharbi GE, Almazroy EA, Elyas SK, Danish HE, Alanazi RT, Aldrees BA, Jadkarim GA, Mikwar Z
Breast Cancer: Targets and Therapy 2025, 17:171-186
Published Date: 18 February 2025
Lactate Dehydrogenase-A-Forming LDH5 Promotes Breast Cancer Progression
Fang T, Hu L, Chen T, Li F, Yang L, Liang B, Wang W, Zeng F
Breast Cancer: Targets and Therapy 2025, 17:157-170
Published Date: 12 February 2025
The Prediction Model of High-Frequency Ultrasound Combined with Artificial Intelligence-Assisted Scoring System Improved the Diagnosis of Sclerosing Adenosis and Early Breast Cancer
Ma B, Wu G, Zhu H, Liu Y, Hu W, Zhao J, Liu Y, Liu Q
Breast Cancer: Targets and Therapy 2025, 17:145-155
Published Date: 7 February 2025
Programmed Cell Death Ligand 1 (PD-L1) and Major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in Triple-Negative Breast Cancer
Kaewkedsri P, Intarawichian P, Jessadapattarakul S, Kunprom W, Koonmee S, Thanee M, Somintara O, Wongbuddha A, Chadbunchachai P, Nawapun S, Aphivatanasiri C
Breast Cancer: Targets and Therapy 2025, 17:123-143
Published Date: 6 February 2025
Analysis of Mammography BI-RADS Distribution and Follow-up Ultrasound Assessment: A Single-Center Study
Kankaya B, Buyukasik S, Altundal YE, Topcu FS, Rahmanbakhsh P, Etemad A, Kapan S, Alis H
Breast Cancer: Targets and Therapy 2025, 17:115-122
Published Date: 6 February 2025
Predicting Axillary Lymph Node Metastasis in Young Onset Breast Cancer: A Clinical-Radiomics Nomogram Based on DCE-MRI
Dong X, Meng J, Xing J, Jia S, Li X, Wu S
Breast Cancer: Targets and Therapy 2025, 17:103-113
Published Date: 27 January 2025
Adipokines in Breast Cancer: Decoding Genetic and Proteomic Mechanisms Underlying Migration, Invasion, and Proliferation
Ließem A, Leimer U, Germann GK, Köllensperger E
Breast Cancer: Targets and Therapy 2025, 17:79-102
Published Date: 25 January 2025
Non-Luminal Disease Score for Everolimus in Patients with Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter and Retrospective Study
Tan Y, Jiang H, Tian X, Ma F, Wang J, Zhang P, Xu B, Fan Y, Zhao W
Breast Cancer: Targets and Therapy 2025, 17:67-78
Published Date: 24 January 2025
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments
Belluzzi L, Martinelli G, Medici B, Farina A, Martinelli E, Canino F, Caggia F, Molinaro A, Barbolini M, Tamburrano F, Moscetti L, Piacentini F, Dominici M, Omarini C
Breast Cancer: Targets and Therapy 2025, 17:53-66
Published Date: 21 January 2025
From Pioneering Discoveries to Innovative Therapies: A Journey Through the History and Advancements of Nanoparticles in Breast Cancer Treatment
Basingab FS, Alshahrani OA, Alansari IH, Almarghalani NA, Alshelali NH, Alsaiary AH, Alharbi N, Zaher KA
Breast Cancer: Targets and Therapy 2025, 17:27-51
Published Date: 21 January 2025
Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer
Zhang JN, Li LW, Cao MQ, Liu X, Yi ZL, Liu SS, Liu H
Breast Cancer: Targets and Therapy 2025, 17:11-25
Published Date: 9 January 2025
Optimizing Xenograft Models for Breast Cancer: A Comparative Analysis of Cell-Derived and Patient-Derived Implantation Techniques in Pre-Clinical Research
Khairani AF, Harmonia S, Chou Y, Alfarafisa NM, Ramadhanti J
Breast Cancer: Targets and Therapy 2025, 17:1-10
Published Date: 9 January 2025